The Creating Hope Act is a rare pediatric disease priority review voucher incentive program approved on 2011

Under this program, a sponsor that develops a drug for a rare pediatric disease and receives FDA approval also receives a fully transferable voucher.

That voucher comes with rights to FDA priority review for any other drug or biologic, including those focused on adults. This would result in the other drug reaching the market much faster, creating significant financial value.

 

Rare pediatric disease PRV awarded so far

PRV_Icon1B.png

Rare pediatric disease PRV cumulative sale price

 
 
PRV_table.png